# House Dust Mite Injection Immunotherapy in Elderly Patients.

> **NCT03209245** · PHASE3 · COMPLETED · sponsor: **Medical University of Silesia** · enrollment: 58 (actual)

## Conditions studied

- Allergen Immunotherapy in Elderly Patients

## Interventions

- **BIOLOGICAL:** Purethal Mites
- **OTHER:** placebo injection
- **DIAGNOSTIC_TEST:** monitoring of allergen specific IgE
- **DIAGNOSTIC_TEST:** monitoring of allergen specific IgG4

## Key facts

- **NCT ID:** NCT03209245
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-10
- **Primary completion:** 2016-06-20
- **Final completion:** 2017-04-15
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03209245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03209245, "House Dust Mite Injection Immunotherapy in Elderly Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03209245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*